The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin nad tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial / M.Cohen, GF.Gensini, F.Maritz, EP.Gurfinkel, K.Huber, A.Timerman, M.Krzeminska-Pakula, N.Danchin, HD.White, J.Santopinto, F.Bigonzi, C.Hecquet, L.Vittori. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - STAMPA. - 42:(2003), pp. 1348-1356.
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin nad tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial
GENSINI, GIAN FRANCO;
2003
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
